Skip to main content

Bordetella Pertussis IgG and IgA Antibodies Seroprevalence Among 1–35 y-old Population: The Role of Subclinical Pertussis Infection

Abstract

Objective

To determine age-dependent pertussis specific IgG and IgA antibodies seroprevalence in apparently healthy subjects.

Methods

A total of 595 healthy 1-35-y-old individuals divided into 5 different age groups were selected from Sari district. Antipertussis IgG and IgA antibodies levels were measured quantitatively by ELISA method. Positive sera for IgA and also IgG titer ≥150 were considered for recent pertussis infection.

Results

High seroprevelence levels (72% and 71%) were observed among preschool (<7 y) children. After decreasing the seroprevelence rates significally to lowest level (54.4%) among school aged (7–11 y), the rates increased again to the highest levels of 60% and 73% at adulthood (P = 0.03 and P = 0.003). In total, 1.55% of study subjects were IgA positive, and 5.7% showed high IgG titers.

Conclusions

The present study reveals, vaccine induced immunity has decreased among school-aged children and natural pertussis infection is common among adolescent and young adults. Also, asymptomatic/sub-clinical recent pertussis infection was prevalent among studied population. These findings necessitate developing new strategies to reduce and control pertussis infection in Iran.

This is a preview of subscription content, access via your institution.

References

  1. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24:S25–34.

    PubMed  Article  Google Scholar 

  2. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005;24:S104–8.

    PubMed  Article  Google Scholar 

  3. Edwards KM, Decker MD, Mortimer EA. Pertussis vaccine. In: Plotkin SA, Orenstein WA, eds. Textbook of vaccine. Philadelphia: Saunders; 1999. pp. 293–344.

    Google Scholar 

  4. Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin C, Demmeler K, eds. Textbook of pediatric infectious diseases. 5th ed. Philadelphia: Saunders; 1588. pp. 1608–2004.

    Google Scholar 

  5. Broutin H, Rohani P, Guégan JF, Grenfell BT, Simondon F. Loss of immunity to pertussis in a rural community in Senegal. Vaccine. 2004;22:594–6.

    PubMed  Google Scholar 

  6. Olin P, Gustafsson L, Barreto L, et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine. 2003;21:2015–21.

    PubMed  Article  Google Scholar 

  7. Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J. 2005;24:721–8.

    PubMed  Article  Google Scholar 

  8. American Academy of Pediatrics. Pertussis. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red book: 2006 report of the committee on infectious diseases. 27th ed. Elk Grove Village: American Academy of Pediatrics; 2006. pp. 498–520.

    Google Scholar 

  9. Expanded programme on immunization, Global Advisory Group. Weekly Epidemiology Record. 1981;56:9–16

    Google Scholar 

  10. Esteghamati MR, Mansour-ghanei R. Guidelines for surveillance of Pertussis (pamphelet). Tehran: Centers for Diseases Control and Prevention. Deputy of Health: Ministry of health and Medical Education; 2009.

  11. Goya MM. pertussis reemergence Notification, Tehran: Centers for Diseases Control and Prevention. Deputy of Health: Ministry of health and Medical Education; No:24740;20 February 2007.

  12. Saffar MJ, Ajami A, Khalilian AR, Qaheri A, Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr. 2007;44:916–8.

    PubMed  CAS  Google Scholar 

  13. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1–65 y. J Infect Dis. 1996;173:1256–9.

    PubMed  Article  CAS  Google Scholar 

  14. Konda T, Kamachi K, Iwaki M, et al. Distribution of pertussis antibodies among different age groups in Japan. Vaccine. 2002;20:1711–7.

    PubMed  Article  CAS  Google Scholar 

  15. García-Corbeira P, Dal-Ré R, Aguilar L, García-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine. 2000;18:2173–6.

    PubMed  Article  Google Scholar 

  16. Baker JD, Halperin SA, Edwards KM, Miller B, Decker M, Stephens D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr. 1992;121:523–7.

    PubMed  Article  CAS  Google Scholar 

  17. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24:S58–61.

    PubMed  Article  Google Scholar 

  18. Thomas MG, Ashworth LA, Miller E, Lambert HP. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. J Infect Dis. 1989;160:838–45.

    PubMed  Article  CAS  Google Scholar 

  19. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000;38:800–6.

    PubMed  Google Scholar 

  20. Eidlitz-Markus T, Mimouni M, Zeharia A. Pertussis symptoms in adolescents and children versus infants: the influence of vaccination and age. Clin Pediatr (Phila). 2007;46:718–23.

    Article  Google Scholar 

  21. Yaari E, Yafe-Zimerman Y, Schwartz SB, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest. 1999;115:1254–8.

    PubMed  Article  CAS  Google Scholar 

  22. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis. 1999;28:S112–7.

    PubMed  Article  Google Scholar 

Download references

Acknowledgements

The authors wish to thanks public health staff for their help in recruiting subjects for this study, and parents of children and children for their participation in this study.

Conflict of Interest

None.

Role of Funding Source

This work was supported by vice-chancellor for research Mazandaran University of Medical Sciences Grant No 8835, 2008.6.24.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammed-Jafar Saffar.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Saffar, MJ., Khalilian, AR., Rafee, AR. et al. Bordetella Pertussis IgG and IgA Antibodies Seroprevalence Among 1–35 y-old Population: The Role of Subclinical Pertussis Infection. Indian J Pediatr 79, 353–357 (2012). https://doi.org/10.1007/s12098-011-0593-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-011-0593-8

Keywords

  • Pertussis
  • Pertussis infection
  • Pertussis IgG seroprevalence
  • Pertussis IgA seroprevalence